Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Interesting post 🥩
I assume he is very well informed. After acquiring Nora Pharma, it is a completely different company
Well that is surprising! I wonder who the Billionaire is buying SBFM?
11 Hyper-Growth Stocks Billionaires Are Loading Up On
Number of Billionaire Investors: 1
Sunshine Biopharma Inc (NASDAQ:SBFM) ranks 11th in our list of the hyper-growth stocks billionaires are loading up on. In November Sunshine Biopharma Inc (NASDAQ:SBFM) posted third quarter results. GAAP EPS in the period came in at -$0.04. Revenue in the quarter totaled $5.96 million.
https://finance.yahoo.com/news/11-hyper-growth-stocks-billionaires-094017302.html
What would happen to my warrants in case of RS. Assume 1/20 split and I have 1000 warrants ?
New S-1 to sell stock and says they'll have to do a RS by March 13 to stay on NASDAQ.
2 New SBFM Officers as of January 25, 2024:
The resumes of the Company’s new officers are as follows:
Malek Chamoun, age 39, was appointed as our Chief Development Officer in January 2024. In 2017 he founded Nora Pharma Inc., a Canadian pharmaceutical company (“Nora Pharma”), based in Montreal, where he has been the President and CEO since inception. We acquired Nora Phara in October 2022. Mr. Chamoun received a bachelor’s degree in business administration from Hautes Études Commerciales, Montreal, Quebec, Canada in 2008 and became a licensed CPA in Canada in 2012. He devotes all of his business time to Nora’s affairs.
Marc Beaudoin, age 57, was appointed as our Chief Operating Officer in January 2024. Mr. Beaudoin has been self-employed as a business strategy consultant, primarily in the pharmaceutical and biopharmaceutical sectors, since 2016. From 2006 to 2016, he held several executive positions at Sandoz Canada in various areas including Marketing and Communications, Strategic Planning, Business Development & Portfolio Management. As an executive and an entrepreneur, he combines expertise in strategic planning with operational and commercial execution. Mr. Beaudoin obtained his MBA from Sherbrooke University in 2018. He also holds multiple certifications (including a fellowship) from the Association for Supply Chain Management.
https://sunshinebiopharma.com/wp-content/uploads/20240130_8k.pdf
Interesting share structure
Interesting stock price, where headed
Interesting company, maybe reverse split again, not scaring anyone
What happen to the cancer supposedly trials, never made it to human trials or I am wrong
I though they would have a cancer cure, probably garbage company jmo
Interesting company mice trials a while back
Interesting point
How did they get all this sales
Wonder anyone own above 10%
Interesting share structure
Nice counterpoint, but seems like meds from Nora Pharma would meet FDA requirements for import. The other main point was the shortages in Canada. That might be a showstopper for any Canadian pharmacy supplier, but I guess we'll find out in the coming months.
Will this help lift Nora Pharma revenue even higher in 2024......
US states are able to seek FDA approval to import prescription drugs from Canada, starting with Florida:
https://finance.yahoo.com/news/1-us-fda-allow-florida-155652532.html
https://finance.yahoo.com/news/florida-gets-first-ever-fda-152106638.html
https://finance.yahoo.com/news/florida-import-prescription-drugs-canada-153101860.html
Followers
|
760
|
Posters
|
|
Posts (Today)
|
5
|
Posts (Total)
|
113752
|
Created
|
10/27/08
|
Type
|
Free
|
Moderators |
SUNSHINE BIOPHARMA INC
ANTI CANCER DRUGS
ANTI CORONA VIRUS RESEARCH
SBFM Transfer Agent
Corporate Stock Transfer
3200 Cherry Creek Dr. South
Suite 430
Denver, CO 80209
(303) 282 - 4800 p
(303) 282 - 5800 f
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |